Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The UCAN Company is a metabolic health and nutrition company that develops and commercializes products based on its proprietary LIVSTEADY technology. Originally developed to treat Glycogen Storage Disease (GSD), LIVSTEADY is a complex carbohydrate that provides a slow, steady release of glucose without the insulin spikes associated with sugar. The company offers a range of energy powders, bars, and gels used by elite athletes, fitness enthusiasts, and individuals with metabolic disorders. UCAN's mission is to provide "smarter energy" that supports performance, recovery, and metabolic health. The technology is backed by clinical trials and is a staple in the fueling strategies of numerous professional and collegiate sports teams.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The UCAN Company.